Singapore’s IHH Healthcare has rolled out a new preventive health programme called Healthspan, aimed at extending the years people live without chronic illness.
AgeQ test anchors the offering
The flagship component, known as AgeQ, evaluates seven blood biomarkers to generate a biological‑age estimate that is compared with a person’s chronological age. The test draws on a reference pool of more than 300,000 individuals, providing a statistical benchmark for each result.
According to the programme details, the assessment is part of a broader four‑step framework labeled LIFT—Learn, Interpret, Finetune, and Track. Participants may select from five screening tiers—AgeQ, Vitals, Foundations, Explorer, and Pioneer—each delivering varying depths of diagnostic insight and clinical follow‑up.
Beyond the initial blood draw, Healthspan promises six core capabilities: baseline health profiling, risk identification, personalised care pathways, team specialist coordination, tailored lifestyle optimisation, and ongoing monitoring with real‑time intervention adjustments.
Related: Angliss Hospital set to open $78m expansion
Integration with IHH’s network
Healthspan links patients to IHH Singapore’s existing infrastructure, which includes four private hospitals, more than 50 clinics, and over 1,500 specialists. The programme also taps resources from the Mount Elizabeth Novena Centre for Genomic Health, operating under the Gleneagles, Mount Elizabeth and Parkway brands.
Peter Chow, chief executive of IHH Healthcare Singapore, said the initiative moves care “upstream from reactive treatment to proactive, predictive and personalised health management.” He added that the goal is to lengthen not only lifespan but also healthspan, defined as the period of life free from illness and disability.
The tiered structure allows individuals to begin with basic vital checks or jump straight into the most extensive Pioneer level, which includes extensive diagnostics and specialist referrals.
While the ambition is clear, its success will depend on how well the predictive models translate into tangible health outcomes for users. The reliance on a large reference database suggests a data‑driven approach, yet real‑world applicability can vary across ethnic groups and lifestyle factors.
Participants receive regular updates.
Related: New Zealand oncology unit cuts travel time for Northland patients
For those considering enrollment, the pathway starts with a simple blood test and proceeds through a series of personalised interventions. Ongoing monitoring is designed to adjust recommendations as new data become available, aiming to keep participants on track toward their health goals.
In the broader context of Singapore’s aging population, a shift toward preventive care could relieve pressure on acute services. By identifying risk factors early, Healthspan may help reduce the incidence of conditions that typically require costly hospital stays.
Critics might point out that the cost of such extensive packages could be prohibitive for some residents, potentially limiting the programme’s reach. However, IHH has not disclosed pricing details, leaving the affordability question open.
Overall, Healthspan represents a notable move by a major private health provider to embed longevity science into routine care. Whether the model will be adopted by other providers remains to be seen, but it adds another layer to Singapore’s evolving health ecosystem.